Medical Management and Device-Based Therapies in Chronic Heart Failure
Publication Title
JSCAI
Document Type
Article
Publication Date
11-1-2023
Keywords
oregon; cards; cards publication
Abstract
Heart failure (HF) remains a major cause of morbidity and mortality worldwide. Major advancements in optimal guideline-directed medical therapy, including novel pharmacological agents, are now available for the treatment of chronic HF including HF with reduced ejection fraction and HF with preserved ejection fraction. Despite these efforts, there are several limitations of medical therapy including but not limited to
Clinical Institute
Cardiovascular (Heart)
Specialty/Research Institute
Cardiology
DOI
10.1016/j.jscai.2023.101206 https
COinS
Comments
Andrew H. Nguyen, DO Madelyn Hurwitz, BS Jacob Abraham, MD Vanessa Blumer, MD M. Casey Flanagan, MD A. Reshad Garan, MD Manreet Kanwar, MD Rachna Kataria, MD Jamie L.W. Kennedy, MD Ajar Kochar, MD, MHS Jaime Hernandez-Montfort, MD, MSc Mohit Pahuja, MD Palak Shah, MD, MS Matthew W. Sherwood, MD, MHS Behnam N. Tehrani, MD Saraschandra Vallabhajosyula, MD, MSc Navin K. Kapur, MD Shashank S. Sinha, MD, MSc